Cite
Evaluation of oral tegafur‐uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non‐distant metastatic TNM stage IV nasopharyngeal carcinoma
MLA
Tsu Yi Chao, et al. “Evaluation of Oral Tegafur‐uracil as Metronomic Therapy Following Concurrent Chemoradiotherapy in Patients with Non‐distant Metastatic TNM Stage IV Nasopharyngeal Carcinoma.” Head & Neck, vol. 41, Aug. 2019, pp. 3775–82. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8948ebb456d2d94fa7a761d465b20ee4&authtype=sso&custid=ns315887.
APA
Tsu Yi Chao, Jia Hong Chen, Jih-Chin Lee, Ching-Liang Ho, & Wen-Yen Huang. (2019). Evaluation of oral tegafur‐uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non‐distant metastatic TNM stage IV nasopharyngeal carcinoma. Head & Neck, 41, 3775–3782.
Chicago
Tsu Yi Chao, Jia Hong Chen, Jih-Chin Lee, Ching-Liang Ho, and Wen-Yen Huang. 2019. “Evaluation of Oral Tegafur‐uracil as Metronomic Therapy Following Concurrent Chemoradiotherapy in Patients with Non‐distant Metastatic TNM Stage IV Nasopharyngeal Carcinoma.” Head & Neck 41 (August): 3775–82. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8948ebb456d2d94fa7a761d465b20ee4&authtype=sso&custid=ns315887.